NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
school
University Rankings
subject
University Subject Rankings
place
Country Rankings
insights
i10 Productivity Rankings
insights
Subject Rankings
format_list_numbered
Top 100 Scientists
format_list_numbered
Citation Rankings
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Erin Kirwin
AD Scientific Index 2024
Business & Management / Decision Science and Operations Management
University of Manchester - Manchester / United Kingdom
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Erin Kirwin's MOST POPULAR ARTICLES
1-)
Estimating (quality‐adjusted) life‐year losses associated with deaths: With application to COVID‐19AH Briggs, DA Goldstein, E Kirwin, R Meacock, A Pandya, DJ Vanness, ...Health Economics 30 (3), 699-707, 2021752021
2-)
Vaccine rollout strategies: The case for vaccinating essential workers earlyN Mulberry, P Tupper, E Kirwin, C McCabe, C ColijnPLOS Global Public Health 1 (10), e0000020, 2021602021
3-)
A conceptual framework for life-cycle health technology assessmentE Kirwin, J Round, K Bond, C McCabeValue in Health 25 (7), 1116-1123, 2022302022
4-)
A net benefit approach for the optimal allocation of a covid-19 vaccineE Kirwin, E Rafferty, K Harback, J Round, C McCabePharmacoEconomics, 1-15, 2021272021
5-)
Early initiation of tumor necrosis factor antagonist–based therapy for patients with Crohn’s disease reduces costs compared with late initiationCL Beilman, E Kirwin, C Ma, C McCabe, RN Fedorak, B HalloranClinical Gastroenterology and Hepatology 17 (8), 1515-1524. e4, 2019192019
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept